Skip to main content
Clinical Trials/NCT04607265
NCT04607265
Completed
N/A

Channel Detection to Predict Ventricular Arrhythmia in Patients With Non-ischemic Cardiomyopathy

Hospices Civils de Lyon0 sites30 target enrollmentJanuary 1, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Non-ischemic Cardiomyopathy
Sponsor
Hospices Civils de Lyon
Enrollment
30
Primary Endpoint
Detect pro arrhythmogenic scar characteristics
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Sudden cardiac death (SCD) risk stratification is a challenge in non-ischemic cardiomyopathy (NICM). The underlying mechanism of monomorphic ventricular tachycardia (VT) is mostly scar related. While electrophysiological mechanisms underlying ventricular arrhythmia are well known, late gadolinium enhanced (LGE) cardiac MRI-3D reconstructions are now able to guide VT ablation procedures. Such exam may help in identifying specific properties of scar at risk of malignant arrhythmia.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
December 1, 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult with NICM
  • Previous history of ventricular tachycardia (VT) and no previous history of VT

Exclusion Criteria

  • Inherited cardiomyopathies
  • Previous history of myocarditis WITHOUT oedema/scar at the MRI

Outcomes

Primary Outcomes

Detect pro arrhythmogenic scar characteristics

Time Frame: baseline : collected at the time of the cardiac MRI

The outcomes will aim to provide scar characteristics from 3D cardiac MRI reconstructions to detect pro arrhythmic properties in NICM patients. Comparisons between NICM patients who experienced VT ablation and NICM patients without history of ventricular arrhythmia will be made. In both groups, Primary outcome will aim to measure the number of the conducting channels into scars (n).

Similar Trials

Recruiting
N/A
Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic CardiomyopathyDilated CardiomyopathyArrhythmogenic CardiomyopathyVentricular ArrhythmiaHypertrophic Cardiomyopathies
NCT06730464Centro Medico Teknon500
Recruiting
N/A
Arrhythmic Risk Stratification in Nonischemic Dilated CardiomyopathySudden Cardiac Death Due to Cardiac ArrhythmiaDilated Cardiomyopathy
NCT04246450University of Athens675
Recruiting
N/A
Cardiovascular Multimodality Imaging StudyNon-ischemic CardiomyopathyCardiomyopathiesHypertrophic CardiomyopathyRight Ventricular Arrhythmogenic CardiomyopathyCardiac AmyloidosisAnderson Fabry DiseaseSarcoidosisCancer Therapy-related Cardiac DysfunctionVentricular ArrythmiaHeart Failure
NCT06610019Montefiore Medical Center5,000
Recruiting
N/A
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.Non-ischemic CardiomyopathyDilated Cardiomyopathy (DCM)Hypertrophic Cardiomyopathy (HCM)Restrictive CardiomyopathyArrhythmogenic Cardiomyopathy (AC, ARVD/C)Left Ventricular NoncompactionArrhythmogenic Mitral Valve ProlapsePeripartum CardiomyopathyAnderson-Fabry DiseaseArrhythmic and Inflammatory Non-ischemic CardiomyopathyInflammatory (Non-Arrhythmic) Non-ischemic CardiomyopathyNonischemic Cardiomyopathy Sensu Strictu (Non-inflammatory, Non-arrhythmic)Major Ventricular Arrhythmias, I.e. Sustained Ventricular Tachycardia, Ventricular Fibrillation, or Appropriate Therapy of Cardiac Device (defibrillators)Overlapping PhenotypeUndefined Phenotypes
NCT06607471Scientific Institute San Raffaele15,000
Completed
N/A
Feasibility Testing of Decision Support for Patients Who Are Candidates for an Implantable DefibrillatorCardiovascular DiseaseSudden Cardiac Death
NCT01876173McMaster University82